Saudi Arabia Animal Pharmaceuticals Market Overview, 2031

Over the past decade, Saudi Arabia’s animal-health landscape has grown alongside its expanding livestock industry and rising pet ownership, reflecting both the country’s focus on food production and shifting societal attitudes toward companion animals. Medicines for livestock and pets including antibiotics, antiparasitic, anti-inflammatories, and hormonal treatments now represent the largest segment of the veterinary-health market, catering to disease prevention, productivity enhancement, and routine care. Technological innovations such as digital livestock monitoring tools, telemedicine, advanced diagnostics, and improved cold chain logistics for biologics have broadened the range and effectiveness of available products, while expansion of veterinary clinics and pharmacies in urban centres has made veterinary care more accessible. Market offerings extend beyond pharmaceuticals to include vaccines, diagnostics, feed additives, and services, with pharmaceuticals continuing to lead in demand. Regulatory oversight ensures that all veterinary medicines meet strict standards for safety, efficacy, and quality, and recent government initiatives such as livestock vaccination mandates have further strengthened animal welfare, food safety, and disease prevention. Demographic and societal shifts, including rising population, increased meat and dairy consumption, and more households adopting pets, are expanding the customer base and raising awareness about animal health. Livestock owners increasingly focus on herd productivity and preventive care, while pet owners seek regular wellness checkups and enhanced pet welfare. Growth in commercial farming, livestock production of poultry, cattle, sheep, and goats, along with the development of veterinary infrastructure, has reinforced the demand for veterinary pharmaceuticals, making Saudi Arabia a leading market in the Middle East for animal-health products and services.

According to the research report, "Saudi Arabia Animal Pharmaceuticals Overview, 2031," published by Bonafide Research, the Saudi Arabia Animal Pharmaceuticals is anticipated to grow at more than 8.5% CAGR from 2026 to 2031.A number of established companies operate in Saudi Arabia’s animal pharmaceutical and veterinary health market, offering a wide range of products and services. A key local manufacturer is Montajat Pharmaceuticals Co. Ltd., based in Dammam, producing antimicrobials, antiparasitics, acaricides, disinfectants, injectable and oral medications, and nutraceuticals for livestock and pets. Other domestic players include Saudi Pharmaceutical Industries (SPI), Mobedco, Al Takamul Agriculture Company, and veterinary-focused distributors. These companies differentiate themselves through product breadth across livestock, poultry, and pets, multiple dosage forms, and integrated offerings such as veterinary medicines combined with feed additives, disinfectants, and biosecurity solutions. Products available in the market include antibiotics, anti parasitics, acaricides, vaccines, medicated feed additives, disinfectants, and nutrition-related solutions. Business models typically involve local manufacturing, import and distribution by regional firms like Arasco, and sales to livestock farms, poultry operations, and companion animal owners. Market trends indicate rising demand for parasiticides and preventive care, alongside increasing adoption of farm hygiene and biosecurity solutions. Promotional strategies emphasize GMP certification, affordability, and multi-functional products, while distribution occurs through veterinary clinics, pharmacies, livestock supply shops, and integrated farm-supply companies. Substitutes include enhanced nutrition, hygiene, and preventive husbandry practices. Approximately 70% of veterinary pharmaceuticals in Saudi Arabia remain imported, highlighting both the challenge and opportunity for local manufacturers. Public data on unit-level sales or licensing/patent filings is limited, with most sources reporting in value terms or market share.

The animal health product landscape in Saudi Arabia encompasses vaccines, antibiotics, antiparasitic, anti inflammatory drugs, growth promoters, reproductive health products, and nutritional supplements. Vaccines cover livestock and companion animals, including inactivated, live attenuated, and recombinant types, with emerging emphasis on thermostable formulations and novel delivery systems that reduce cold chain dependence and support the one health approach by limiting zoonotic risks. Antibiotics and antimicrobials remain a major therapeutic class, with long acting formulations increasingly introduced to improve compliance and treatment outcomes, and these are distributed through veterinary pharmacies, agricultural supply stores, online platforms, and direct farm sales. The antiparasitic segment covering ectoparasiticides, endoparasiticides, and combination products continues to grow, driven by rising pet ownership and livestock health needs, with regulatory approvals required before sale. Anti inflammatory drugs, including NSAIDs, address pain, inflammation, and conditions such as mastitis or lameness, reflecting a trend toward comprehensive veterinary care. Growth promoters and medicated feed additives, including amino acids, vitamins, and antibiotics, support livestock productivity, though regulatory scrutiny exists over residues and antimicrobial resistance. Reproductive-health products, including hormonal therapies and breeding aids, are important in commercial livestock operations to optimize herd performance. Nutritional supplements for livestock and pets, delivered via feed additives or standalone products, support wellness, immunity, and growth, with rising awareness of preventive care boosting demand. Key trends include species specific and long acting antibiotics, recombinant or nanoparticle enhanced vaccines, and greater focus on feed-based growth and nutrition, while regulatory factors, cold chain logistics, and consumer awareness influence adoption across these product types.

In Saudi Arabia and the broader region, production animals such as cattle, poultry, sheep, and goats dominate the animal health market, reflecting their central role in food security and large herd volumes. Cattle, both dairy and beef, lead in value share due to intensive operations and high health-management needs, including disease control, mastitis prevention, reproductive care, and metabolic monitoring. Sheep and goats are significant because of cultural and traditional demand for meat, facing high parasite and infection burdens that drive consumption of medicines, vaccines, and dewormers. Poultry also contributes substantially, reflecting its prominence in regional consumption patterns. Livestock products include therapeutics like antibiotics, antiparasitics, anti-inflammatories, vaccines, feed-additives, diagnostics, and veterinary services, with trends showing growing adoption of preventive care, herd-health management, vaccination campaigns, and biosecurity measures supported by government initiatives and food-security concerns. The companion-animal segment, led by dogs and cats, is among the fastest-growing markets, fueled by rising urban pet ownership, higher disposable incomes, and increased awareness of preventive and wellness care, with products ranging from therapeutics and vaccines to supplements, diagnostics, and veterinary clinic services. Horses and exotic pets represent a smaller portion of demand. Aquaculture, including fish and shrimp, is recognized but remains a smaller contributor to animal-health revenue, with products such as anti-infectives, antiparasitics, feed-additives, and diagnostics tailored to aquatic species. Growth in this segment is linked to seafood demand and emerging aquaculture initiatives. Distribution channels vary by animal type, with livestock relying on direct farm sales and distributors, while companion animals depend on veterinary clinics, pharmacies, and online retail. Challenges include regulatory gaps, misuse of antibiotics, limited specialized veterinary products for aquaculture, infrastructure constraints, and lower penetration of advanced pet-care services in non-urban areas.

In Saudi Arabia, veterinary hospitals and clinics serve as a primary channel for both companion-animal and livestock pharmaceuticals, offering products directly during consultations, treatments, and vaccination campaigns, while also providing guidance on preventive care, nutrition, and herd management, which builds customer trust and encourages repeat purchases. Companion-animal owners rely on clinics for vaccines, therapeutics, anti-parasitics, and wellness products, whereas livestock owners use clinics for disease diagnosis and treatment of sick animals. Animal pharmacies and agro-pharmacies complement this by selling veterinary drugs, feed additives, nutritional supplements, and vaccines directly to urban and rural livestock farmers, as well as pet owners, often stocking generic and branded products at competitive prices and offering limited advisory support. Online distribution platforms are increasingly popular for companion-animal products, providing convenience through doorstep delivery, subscription services, and educational content, although their adoption for livestock is limited due to bulk volumes and regulatory restrictions. Direct sales to farms are common for large dairy, poultry, or integrated livestock operations, enabling bulk purchases, customized orders, technical support, and coordination with farm veterinarians, which is essential for preventive health and biosecurity. Veterinary distributors bridge manufacturers and end-users, handling warehousing, logistics, regulatory compliance, and supply of both domestic and imported products across pharmaceuticals, vaccines, and feed additives, allowing smaller or international manufacturers to access the Saudi market efficiently. Trust is strongest in clinics, convenience is higher in pharmacies and online platforms, and bulk efficiency drives direct farm sales and distributor operations, with pricing, promotions, and product bundling influencing adoption and repeat purchases, while regulatory oversight ensures prescription-only drugs are sold through authorized channels.



Considered in this report
• Historic year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Saudi Arabia Animal Pharmaceuticals Market with its value and forecast along with its segments
• Country-wise Animal Pharmaceuticals Market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Vaccines
• Antibiotics and Antimicrobials
• Antiparasitic Agents
• Anti-inflammatory Drugs
• Growth Promoters
• Reproductive Health Products
• Nutritional Supplements

By Animal Type
• Livestock (Cattle, Swine, Poultry, Sheep)
• Companion Animals (Dogs, Cats, Horses)
• Aquaculture Species

By Distribution Channel
• Veterinary Hospitals and Clinics
• Animal Pharmacies and Retailers
• Online Distribution Platforms
• Direct Sales to Farms
• Veterinary Distributors